Demonacos C - Search Results

1

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment.

Guazzelli A, Meysami P, Bakker E, Demonacos C, Giordano A, Krstic-Demonacos M, Mutti L. Guazzelli A, et al. Among authors: demonacos c. Int J Mol Sci. 2019 Jan 19;20(2):429. doi: 10.3390/ijms20020429. Int J Mol Sci. 2019. PMID: 30669483 Free PMC article.

2

Immunotherapy advances for mesothelioma treatment.

Bakker E, Guazzelli A, Ashtiani F, Demonacos C, Krstic-Demonacos M, Mutti L. Bakker E, et al. Among authors: demonacos c. Expert Rev Anticancer Ther. 2017 Sep;17(9):799-814. doi: 10.1080/14737140.2017.1358091. Epub 2017 Jul 31. Expert Rev Anticancer Ther. 2017. PMID: 28724330 Free article. Review.

3

Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer.

Alhebshi H, Tian K, Patnaik L, Taylor R, Bezecny P, Hall C, Muller PAJ, Safari N, Creamer DPM, Demonacos C, Mutti L, Bittar MN, Krstic-Demonacos M. Alhebshi H, et al. Among authors: demonacos c. Int J Mol Sci. 2021 Dec 7;22(24):13198. doi: 10.3390/ijms222413198. Int J Mol Sci. 2021. PMID: 34947995 Free PMC article.

4

p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification.

Tian K, Bakker E, Hussain M, Guazzelli A, Alhebshi H, Meysami P, Demonacos C, Schwartz JM, Mutti L, Krstic-Demonacos M. Tian K, et al. Among authors: demonacos c. J Transl Med. 2018 Oct 13;16(1):282. doi: 10.1186/s12967-018-1650-0. J Transl Med. 2018. PMID: 30316293 Free PMC article.

5

What can independent research for mesothelioma achieve to treat this orphan disease?

Guazzelli A, Meysami P, Bakker E, Bonanni E, Demonacos C, Krstic-Demonacos M, Mutti L. Guazzelli A, et al. Among authors: demonacos c. Expert Opin Investig Drugs. 2019 Aug;28(8):719-732. doi: 10.1080/13543784.2019.1638363. Epub 2019 Jul 1. Expert Opin Investig Drugs. 2019. PMID: 31262194 Review.

6

Quantitative analysis and modeling of glucocorticoid-controlled gene expression.

Chen DW, Lynch JT, Demonacos C, Krstic-Demonacos M, Schwartz JM. Chen DW, et al. Among authors: demonacos c. Pharmacogenomics. 2010 Nov;11(11):1545-60. doi: 10.2217/pgs.10.125. Pharmacogenomics. 2010. PMID: 21121775

7

Regulation of CXCR4 gene expression in breast cancer cells under diverse stress conditions.

Andreou K, Rajendran R, Krstic-Demonacos M, Demonacos C. Andreou K, et al. Among authors: demonacos c. Int J Oncol. 2012 Dec;41(6):2253-9. doi: 10.3892/ijo.2012.1643. Epub 2012 Sep 27. Int J Oncol. 2012. PMID: 23023398

8

The role of microenvironment and immunity in drug response in leukemia.

Bakker E, Qattan M, Mutti L, Demonacos C, Krstic-Demonacos M. Bakker E, et al. Among authors: demonacos c. Biochim Biophys Acta. 2016 Mar;1863(3):414-426. doi: 10.1016/j.bbamcr.2015.08.003. Epub 2015 Aug 6. Biochim Biophys Acta. 2016. PMID: 26255027 Free article. Review.

9

Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.

Guazzelli A, Bakker E, Tian K, Demonacos C, Krstic-Demonacos M, Mutti L. Guazzelli A, et al. Among authors: demonacos c. Expert Opin Investig Drugs. 2017 Aug;26(8):933-944. doi: 10.1080/13543784.2017.1351545. Epub 2017 Jul 12. Expert Opin Investig Drugs. 2017. PMID: 28679291 Free article. Review.

10

Insight into glucocorticoid receptor signalling through interactome model analysis.

Bakker E, Tian K, Mutti L, Demonacos C, Schwartz JM, Krstic-Demonacos M. Bakker E, et al. Among authors: demonacos c. PLoS Comput Biol. 2017 Nov 6;13(11):e1005825. doi: 10.1371/journal.pcbi.1005825. eCollection 2017 Nov. PLoS Comput Biol. 2017. PMID: 29107989 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters